AU2003246255A1 - Method of screening anticancer agent - Google Patents

Method of screening anticancer agent

Info

Publication number
AU2003246255A1
AU2003246255A1 AU2003246255A AU2003246255A AU2003246255A1 AU 2003246255 A1 AU2003246255 A1 AU 2003246255A1 AU 2003246255 A AU2003246255 A AU 2003246255A AU 2003246255 A AU2003246255 A AU 2003246255A AU 2003246255 A1 AU2003246255 A1 AU 2003246255A1
Authority
AU
Australia
Prior art keywords
anticancer agent
screening anticancer
screening
agent
anticancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003246255A
Inventor
Tasuku Honjo
Kiyotsugu Yoshikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2003246255A1 publication Critical patent/AU2003246255A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003246255A 2002-07-05 2003-07-03 Method of screening anticancer agent Abandoned AU2003246255A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002196764A JP2004033137A (en) 2002-07-05 2002-07-05 Method for screening anticancer agent
JP2002-196764 2002-07-05
PCT/JP2003/008470 WO2004005538A1 (en) 2002-07-05 2003-07-03 Method of screening anticancer agent

Publications (1)

Publication Number Publication Date
AU2003246255A1 true AU2003246255A1 (en) 2004-01-23

Family

ID=30112374

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003246255A Abandoned AU2003246255A1 (en) 2002-07-05 2003-07-03 Method of screening anticancer agent

Country Status (3)

Country Link
JP (1) JP2004033137A (en)
AU (1) AU2003246255A1 (en)
WO (1) WO2004005538A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008103475A1 (en) * 2007-02-20 2008-08-28 Anaptysbio, Inc. Somatic hypermutation systems

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1174509A4 (en) * 1999-03-29 2003-10-22 Kansai Tech Licensing Org Co Novel cytidine deaminase
ATE417825T1 (en) * 1999-11-01 2009-01-15 Nalan Utku NEW GENES TZAP7/A, TZAP7/B AND TZAP7 INVOLVED IN T CELL ACTIVATION AND THEIR USES
CA2440809A1 (en) * 2001-03-01 2002-09-12 Conforma Therapeutics Corp. Methods for treating genetically-defined proliferative disorders with hsp90 inhibitors

Also Published As

Publication number Publication date
WO2004005538A1 (en) 2004-01-15
JP2004033137A (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2003277596A1 (en) Method of deuterization
AU2003222209A1 (en) Method of manufacturing refiner elements--.
AU2003269126A1 (en) Method of combining materials
AU2003277663A1 (en) Screening method
AU2002249467A1 (en) Screening method
AUPS096002A0 (en) Method of construction
AU2003242340A1 (en) Novel screening method
AU2003296451A1 (en) Method of reducing toxicity of anticancer agents
AU2003246255A1 (en) Method of screening anticancer agent
AU2003227268A1 (en) Novel screening method
AU2002323034A1 (en) Method of screening for drug hypersensitivity reaction
AU2003254579A1 (en) Methods of screening for schizophrenia
AU2003202622A1 (en) A method of screening
AU2002952966A0 (en) Screening apparatus
AU2003242342A1 (en) Novel screening method
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
AU2002354247A1 (en) Screening method
AU2003217008A1 (en) Screening method
AU2002354206A1 (en) Method of screening drug
AU2003290512A1 (en) Method of weldbonding
AU2003299623A1 (en) Method of making mercaptoalkylalkyldialkoxysilanes
AU2003222584A1 (en) Method of producing organoacyloxysilanes
AU2003285006A1 (en) Method of preparation of oligosaccharides
AU2003248955A1 (en) Screening method
AU2003241904A1 (en) Novel method of screening

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase